Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
about
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
description
article
@en
im November 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Safety, tolerability, and phar ...... 2a randomized controlled trial
@en
Safety, tolerability, and phar ...... 2a randomized controlled trial
@nl
type
label
Safety, tolerability, and phar ...... 2a randomized controlled trial
@en
Safety, tolerability, and phar ...... 2a randomized controlled trial
@nl
prefLabel
Safety, tolerability, and phar ...... 2a randomized controlled trial
@en
Safety, tolerability, and phar ...... 2a randomized controlled trial
@nl
P2093
P50
P1433
P1476
Safety, tolerability, and phar ...... 2a randomized controlled trial
@en
P2093
Adeola Adeyeye
Alex R Rinehart
David Burns
David Margolis
Gordon Chau
Halima Dawood
Leslie Cottle
Manya Magnus
Marybeth McCauley
Myron S Cohen
P304
P356
10.1371/JOURNAL.PMED.1002690
P407
P50
P577
2018-11-08T00:00:00Z